logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
Purified Anti-human CD11c Antibody
3.9
3.9 is an anti-human monoclonal antibody that forms an immune complex with the CD11c antigen. CD11c (sometimes called CR4 or ITGAX) is a 145 - 150 kD single-pass type I membrane protein that is expressed on the surface of cells such as macrophages, B cells and dendritic cells. In some organisms, CD11c promotes angiogenesis, positively regulates myelination and is a promoter of endothelial tube morphogenesis. Moreover, it is a component of essential cellular pathways, in particular, the cytokine-mediated signaling pathway and integrin-mediated signaling pathway. From a research standpoint, it is of biological interest due to its association with vital macromolecules/ligands like ICAM-1 and 4 and fibrinogen. CD11c is a very popular antibody target, with over 26000 publications in the last decade. CD11c has been widely used in costimulatory molecules research, commonly serving as a phenotypic marker for differentiating cell types in flow cytometric applications. This antibody was purified through affinity chromatography.
General packaging for catalog 10113000. Actual shipped packaging may vary.
General packaging for catalog 10113000. Actual shipped packaging may vary.
CatalogSize
Price
Quantity
10113000100 ug
Price
 
Physical properties

Molecular weightN/A
Solventwater
Antibody properties

Other namesIntegrin alpha-X; CR4; p150; ITGAX
Clone3.9
Hostmouse
IsotypeMouse IgG1, κ
Reactivityhuman
ApplicationFlow Cytometry (FACS); ELISA; IHC; Western Blot
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
StorageRefrigerated (2-8 °C); Minimize light exposure
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on October 20, 2025